The trademark CURIA was filed by INNOPLEXUS AG, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on May 4, 2020, and received one opposition filed on July 30, 2020 by Unit4 Cura B.V. on Likelihood of confusion. the opponent was represented by PLOUM and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued July 30, 2020
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).
Change of name and professional address of the trademark registration was recorded on October 26, 2021.
Goods And Services
The mark was filed in class 9 with following description of goods:
Downloadable software
Computer software
Computer software relating to the medical field
Downloadable mobile applications
Software applications for use with mobile devices
Computer software for creating searchable databases of information and data
Computer software for authorizing access to data bases
Computer application software for providing information related to life sciences and pharma domain using proprietary and non-proprietary databases
Downloadable mobile applications for providing information related to life sciences and pharma domain using proprietary and non-proprietary databases
Downloadable mobile applications for the management of information
Downloadable mobile applications for the transmission of information
All of the aforementioned goods being explicitly only rendered in the field of cancer treatment, cancer patient information and assistance, cancer treatment and clinical trial information.
The mark was filed in class 42 with following description of goods:
Developing computer software
Development and design of software in the field of mobile applications
Medical research services
Medical and pharmacological research services
Renting computer software
Computer software consulting
Research on the subject of pharmaceuticals
Computer programming in the medical field
Scientific investigations for medical purposes
Scientific research for medical purposes in the area of cancerous diseases
Research and development in the pharmaceutical and biotechnology fields
Providing scientific information in the field of medical disorders and their treatment
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
All of the aforementioned services being explicitly only rendered in the field of cancer treatment, cancer patient information and assistance, cancer treatment and clinical trial information.